Surgical Management of Intraocular Pressure With Ab Interno Canaloplasty in Postkeratoplasty Patients: 12-Month Results
- 4 March 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Cornea
- Vol. 42 (1) , 52-59
Abstract
Purpose: The purpose of this study was to report clinical outcomes of ab interno canaloplasty (ABiC) with the iTrack microcatheter (Nova Eye Medical, Fremont, CA) for surgical management of intraocular pressure (IOP) in postkeratoplasty patients. Methods: This study was a single-center retrospective case series of postkeratoplasty eyes undergoing ABiC. Efficacy was evaluated based on graft survivability and mean reduction in IOP at 12 months postoperatively. Secondary end points consisted of visual acuity outcomes, number of topical hypotensive medications, and rate of complications. Results: ABiC was successfully performed in 17 eyes after keratoplasty (8 penetrating keratoplasty, 6 DSAEK, 2 penetrating keratoplasty + DSAEK, and 1 DMEK) with elevated IOP refractory to topical hypotensive medications. The baseline mean IOP was 26.2 ± 8.4 mm Hg and reduced significantly to 15.0 ± 4.21 mm Hg at 6 months and 13.0 ± 2.99 mm Hg at 12 months (P < 0.005). The best-corrected visual acuity improved from 0.61 ± 0.55 logMAR at baseline to 0.47 ± 0.59 and 0.49 ± 0.64 at 6 and 12 months, respectively, following ABiC (not statistically significant: P = 0.6769). The baseline mean number of topical hypotensive medications was 3.7 ± 1.8 and reduced to 2.7 ± 1.4 and 2.9 ± 1.3 at 6 and 12 months, respectively (P = 0.096). One patient developed a hyphema which required anterior chamber washout. One patient required additional glaucoma surgery 19 months after ABiC. No patients experienced graft failure. Conclusions: ABiC is a clinically safe and effective treatment that can be performed in postkeratoplasty patients to reduce IOP for at least 1 year without any significant complications.Keywords
This publication has 27 references indexed in Scilit:
- Influence of BAK-Preserved Prostaglandin Analog Treatment on the Ocular Surface Health in Patients with Newly Diagnosed Primary Open-Angle GlaucomaBioMed Research International, 2013
- Glaucoma in penetrating keratoplasty: risk factors, management and outcomeGraefe's Archive for Clinical and Experimental Ophthalmology, 2012
- Risk Factors for Intraocular Pressure Elevation After Descemet Stripping Automated Endothelial KeratoplastyEye & Contact Lens: Science & Clinical Practice, 2010
- Incidence of and Risk Factors for Increased Intraocular Pressure After Penetrating KeratoplastyCornea, 2010
- Impact on the Corneal Endothelium of Mitomycin C During Photorefractive KeratectomyJournal of Refractive Surgery, 2009
- Management of patients with combined glaucoma and corneal transplant surgeryEye, 2009
- Long-term Topical Steroid Treatment Improves Graft Survival Following Normal-risk Penetrating KeratoplastyAmerican Journal of Ophthalmology, 2007
- Three and Five Year Changes in Intraocular Pressures After Clear Corneal Phacoemulsification in Open Angle Glaucoma Patients, Glaucoma Suspects, and Normal PatientsJournal of Glaucoma, 2006
- Risk Factors for Various Causes of Failure in Initial Corneal GraftsArchives of Ophthalmology (1950), 2003
- Long-term results of eyes with penetrating keratoplasty and glaucoma drainage tube implantOphthalmology, 2001